Free · Substack Nov 2, 2026 · 1 min read

Afternoon update

$LITE fell 16.57% and Marvell 10.68% this afternoon as investor skepticism grew over Marvell's $115B all-stock acquisition of Lumentum. • Lumentum…

Afternoon update
Intraday Movers · Afternoon · Intraday Movers — November 2 AFTERNOON · Mon, Nov 2

$LITE fell 16.57% and Marvell 10.68% this afternoon as investor skepticism grew over Marvell's $115B all-stock acquisition of Lumentum.

  • Lumentum closed at $701.43 ($62.9B market cap). The deal, valued at $115B by enterprise value, gives Marvell shareholders 67% of the combined company and is expected to close in H1 2028. Shares have fallen sharply since talks surfaced.
  • Marvell slid to $175.43 ($152.9B) as investors questioned whether it is overpaying and taking on too much at once in its race with Broadcom for AI data-center optical and custom-chip business.
  • IDEXX rose 20.28% to $663.02 after Q3 non-GAAP EPS of $3.96 beat by $0.25 and revenue of $1.21B grew 10%. FY26 revenue guidance rose to $4,741-$4,767M on higher diagnostic use.
  • Tempus AI gained 9.97% to $79.42 on revenue of $411.5M, up 23.1%, and adjusted EBITDA of $25.6M versus $1.5M a year ago. Rivian added 9.75% after UBS upgraded it to Buy with a $17 target.
  • Indices held flat: S&P 500 +0.13% at 7590.16, Nasdaq -0.12% at 25406.43.

Historically, Lumentum has been higher one year after 83% of its seven -16% drops, with a median gain of +77.7%. The open question is how much a pending $115B merger changes that pattern.

Not financial advice. For informational and educational purposes only.

Originally published on the Position Tracker Substack. Read on Substack ↗

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →